Orange County Research Center

Tustin, California 92790

2 studies enrolling now · 129 studies all time

What they study most

ADHF, Acquired Immunodeficiency Syndrome, Acute Gout, Advanced Malignancies, Allergic Rhinitis, Allergic Rhinitis Due to Grass Pollen, Arthritis, Rheumatoid, Atherosclerosis, Atherosclerotic Cardiovascular Disease, Atopic Dermatitis, Atopic Dermatitis Eczema, Atopic Immunoglobulin E-Mediated Allergic Disorder

Studies at this site

• A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure — Recruiting now
• Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434 — Recruiting now
• A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors — Completed
• A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults — Running, not enrolling
• A Study of Enicepatide (CT-388) in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity — Completed
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AMG 890 in Subjects With Elevated Plasma Lipoprotein(a) — Completed
• Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus — Completed
• An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients. — Completed
• Single and Multiple Ascending Dose Study of AMG 133 in Participants With Obesity — Completed
• Single and Multiple Ascending Dose Study to Evaluate AMG 786 in Healthy Participants and Participants With Obesity — Completed
• A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults — Completed
• Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies — Completed
• A Study of Effect of Selpercatinib (LY3527723) in Participants With Normal and Impaired Renal Function — Completed
• A Study to Evaluate the Pharmacokinetics and Safety of INCB054707 in Participants With Normal Hepatic Function and Participants With Hepatic Impairment — Completed
• A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza — Completed
• A Pharmacokinetic Study of Omaveloxolone in Subjects With Hepatic Impairment and Normal Hepatic Function — Completed
• A Study to Learn How the Study Medicine Called PF-07275315 Works in Healthy People — Completed
• Glycemic Response in Persons With Type 2 Diabetes Mellitus — Completed
• A Study of Effects of Selpercatinib in Hepatically Impaired Participants and Healthy Participants — Completed
• Phase 1 Study of PK and Safety of HM15912 (Sonefpeglutide) in Subjects With Normal and Severe Kidney Function — Completed
• A Study to Learn About Study Medicine Called PF-07261271 in Healthy People — Completed
• Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) — Completed
• A Study to Compare How the Study Medicine (PF-07923568) is Processed in Participants With Different Levels of Loss of Liver Function to Healthy Participants. — Completed
• Efficacy and Safety of Human Neuregulin-1 to Treat Stable Chronic Heart Failure — Completed
• Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Liver Function and Healthy Participants — Completed
• A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV). — Completed
• A Study About How ASP5354 Affects the Body in Healthy Adults and in Adults Whose Kidneys do Not Work Well — Completed
• Glycemic Response in Adults with Diabetes — Completed
• Glucose Response in Persons with Type 2 Diabetes — Completed
• Glycemic Response in Persons with Type 2 Diabetes — Completed
• A Study to Investigate Safety, Tolerability, and PK of Oral Doses of TCK-276 in Patients With Rheumatoid Arthritis — Completed
• Evaluate Effects of Sprinkled Format REDUCOSE in a Carbohydrate-rich, Mixed Meal on Post-prandial Glycemia — Completed
• Study of GBT021601 in Participants With Renal Impairment — Stopped early
• A Study to Evaluate the Effects of Pre-Meal Whey Protein Microgels Administration on Post-Prandial Glycemic Response. — Completed
• Single and Multiple Ascending Dose Study of AMG 171 in Subjects With Obesity — Stopped early
• A Study to Learn About the Study Medicine (Called Lorlatinib) in People With Liver Dysfunction — Completed
• A Study to Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH) — Completed
• Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis — Completed
• Pharmacokinetics of Sotorasib in Healthy Participants and Participants With Moderate or Severe Hepatic Impairment — Completed
• Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of Age — Completed
• A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza — Completed
• Safety and Tolerability of NTRX-07 in Healthy Volunteers — Completed
• Single Ascending Dose of AMG 609 in Participants With Non-alcoholic Fatty Liver Disease — Completed
• A Study to Evaluate the Effect of Mild, Moderate, and Severe Hepatic Impairment on Pharmacokinetics of Sitravatinib — Completed
• A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function — Completed
• Multiple Ascending Dose Study of AMG 598 in Adults With Obesity — Completed
• Study to Estimate the Effects of Hepatic Impairment on the Pharmacokinetics (PK) of PF-07321332 — Completed
• A Drug-Drug Interaction Study Between PF-06882961 and PF-06865571 in Healthy Adult Participants and Overweight Adults or Adults With Obesity Who Are Otherwise Healthy — Completed
• Pharmacokinetic and Safety Study of Naltrexone Release From Subcutaneous BICX104 Pellets Compared to Vivitrol Injections — Completed
• Renal Impairment Study of PF-07321332 Boosted With Ritonavir in Adult Participants With Renal Impairment and in Healthy Participants With Normal Renal Function. — Completed